Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia.

Järbrink, K; Kreif, N; Benedict, A; Locklear, J; (2009) Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia. Current medical research and opinion, 25 (3). pp. 709-16. ISSN 0300-7995 DOI: https://doi.org/10.1185/03007990902738810

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1185/03007990902738810

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar